ArticleAnnals of pediatric cardiology
Risk of sudden cardiac death due to inorganic pyrophosphate A2 deficiency in a Pakistani infant: Diagnostic and management challenges in low-resource settings.
Article in Annals of pediatric cardiology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Inorganic pyrophosphate A2 (PPA2) deficiency is a rare autosomal recessive mitochondrial disorder associated with cardiomyopathy and sudden cardiac death (SCD). Limited cases have been reported globally, with none documented in Pakistan. This case reports the first genetically confirmed case of PPA2 deficiency in an asymptomatic, 13-month-old Pakistani male. Following the sudden death of his sibling, a cardiac and genetic evaluation was performed. Whole-exome sequencing revealed a homozygous mutation in the patient's PPA2 gene, with parents being carriers. A multidisciplinary management approach was adopted, focusing on lifestyle modification and risk mitigation. Diagnostic challenges and the importance of genetic evaluation in families with unexplained SCD, particularly in regions of high levels of consanguinity, are highlighted. Individuals with a family history of SCD should be screened for any genetic predisposition to cardiac disease. Strengthening investigative services and adopting a multidisciplinary approach is essential for early diagnosis and management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.